COLEC10
geneOn this page
Also known as CL-L1CL-10
Summary
COLEC10 (collectin subfamily member 10, HGNC:2220) is a protein-coding gene on chromosome 8q24.12, encoding Collectin-10 (Q9Y6Z7). Lectin that binds to various sugars: galactose > mannose = fucose > N-acetylglucosamine > N-acetylgalactosamine.
This gene encodes a member of the C-lectin family, proteins that possess collagen-like sequences and carbohydrate recognition domains. The other members of this family are secreted proteins and bind to carbohydrate antigens on microorganisms facilitating their recognition and removal. This gene product is a cytosolic protein, a characteristic that suggests that it may have different biological functions than other C-lectins.
Source: NCBI Gene 10584 — RefSeq curated summary.
At a glance
- Gene–disease (curated): 3MC syndrome 3 (Strong, GenCC) — +1 more curated relationship
- GWAS associations: 17
- Clinical variants (ClinVar): 63 total — 4 pathogenic, 2 likely-pathogenic
- Phenotypes (HPO): 48
- MANE Select transcript:
NM_006438
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2220 |
| Approved symbol | COLEC10 |
| Name | collectin subfamily member 10 |
| Location | 8q24.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CL-L1, CL-10 |
| Ensembl gene | ENSG00000184374 |
| Ensembl biotype | protein_coding |
| OMIM | 607620 |
| Entrez | 10584 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000332843, ENST00000521788, ENST00000892374, ENST00000892375, ENST00000892376, ENST00000892377, ENST00000892378
RefSeq mRNA: 2 — MANE Select: NM_006438
NM_001324095, NM_006438
CCDS: CCDS6327
Canonical transcript exons
ENST00000332843 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001304898 | 119105800 | 119108455 |
| ENSE00001309494 | 119067247 | 119067429 |
| ENSE00001325106 | 119103800 | 119103895 |
| ENSE00003497438 | 119089680 | 119089751 |
| ENSE00003540400 | 119102348 | 119102401 |
| ENSE00003671329 | 119091149 | 119091220 |
Expression profiles
Bgee: expression breadth broad, 91 present calls, max score 85.41.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5356 / max 127.6159, expressed in 85 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 90372 | 0.2763 | 48 |
| 90371 | 0.1388 | 34 |
| 90370 | 0.0687 | 25 |
| 90369 | 0.0517 | 16 |
Top tissues by expression
259 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 85.41 | gold quality |
| liver | UBERON:0002107 | 78.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.63 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.53 | gold quality |
| right lung | UBERON:0002167 | 62.51 | gold quality |
| gall bladder | UBERON:0002110 | 58.46 | gold quality |
| heart left ventricle | UBERON:0002084 | 58.16 | gold quality |
| cardiac ventricle | UBERON:0002082 | 57.57 | gold quality |
| adrenal tissue | UBERON:0018303 | 57.45 | gold quality |
| pancreatic ductal cell | CL:0002079 | 57.01 | silver quality |
| islet of Langerhans | UBERON:0000006 | 55.86 | gold quality |
| apex of heart | UBERON:0002098 | 55.45 | gold quality |
| right coronary artery | UBERON:0001625 | 53.07 | gold quality |
| placenta | UBERON:0001987 | 52.44 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 52.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.88 | gold quality |
| heart | UBERON:0000948 | 51.82 | gold quality |
| colonic epithelium | UBERON:0000397 | 51.76 | gold quality |
| metanephros cortex | UBERON:0010533 | 51.61 | gold quality |
| tibial artery | UBERON:0007610 | 51.45 | gold quality |
| thyroid gland | UBERON:0002046 | 51.44 | gold quality |
| lung | UBERON:0002048 | 51.41 | gold quality |
| popliteal artery | UBERON:0002250 | 51.38 | gold quality |
| cortical plate | UBERON:0005343 | 51.10 | silver quality |
| calcaneal tendon | UBERON:0003701 | 51.06 | silver quality |
| metanephros | UBERON:0000081 | 51.02 | gold quality |
| ileal mucosa | UBERON:0000331 | 50.96 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 50.68 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 50.66 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7407 | yes | 1021.67 |
| E-ANND-3 | no | 4.24 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
86 targeting COLEC10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-139-5P | 99.80 | 69.50 | 1399 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
Literature-anchored findings (GeneRIF, showing 11)
- Most plasma CL-K1 was found in complex with CL-L1 in a ratio suggesting a heteromeric subunit of 1 CL-L1 & 2 CL-K1 polypeptides. (PMID:24174618)
- Carriers of COLEC10 Arg125Trp had increased CL-L1 serum levels. (PMID:25710878)
- Data indicate differences in the plasma concentrations of collectin liver 1 and collectin kidney 1, M-ficolin and H-ficol in systemic lupus erythematosus (SLE) patients compared to a group of healthy controls. (PMID:26154564)
- high serum CL-L1 concentration in critically ill children upon PICU admission is associated with an increased risk of infection and prolonged need of intensive care, and counteracts the protective effect of having a high MASP-3 concentration (PMID:27057739)
- High CLL1 expression is associated with cardiovascular disease. (PMID:27341702)
- Exome sequencing reveals mutations in collectin sub-family member 10 (C-type lectin) protein (COLEC10) as a cause of 3MC syndrome with main features include facial dysmorphism, craniosynostosis and cleft lip/palate. (PMID:28301481)
- Collectin liver 1 (CL-L1, collectin 10) and collectin kidney 1 (CL-K1, collectin 11) were found widespread and almost identical tissue with a high expression in epithelial cells in endo-/exocrine secretory tissues and mucosa. (PMID:30108587)
- Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome. (PMID:32751929)
- A novel COLEC10 mutation in a child with 3MC syndrome. (PMID:34740859)
- COLEC10 Induces Endoplasmic Reticulum Stress by Occupying GRP78 and Inhibits Hepatocellular Carcinoma. (PMID:36925047)
- The C-type lectin COLEC10 is predominantly produced by hepatic stellate cells and involved in the pathogenesis of liver fibrosis. (PMID:38036508)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | COLEC10 | ENSDARG00000104752 |
| mus_musculus | Colec10 | ENSMUSG00000038591 |
| rattus_norvegicus | Colec10 | ENSRNOG00000008591 |
Paralogs (4): COLEC11 (ENSG00000118004), SFTPA1 (ENSG00000122852), SFTPD (ENSG00000133661), SFTPA2 (ENSG00000185303)
Protein
Protein identifiers
Collectin-10 — Q9Y6Z7 (reviewed: Q9Y6Z7)
Alternative names: Collectin liver protein 1, Collectin-34
All UniProt accessions (1): Q9Y6Z7
UniProt curated annotations — full annotation on UniProt →
Function. Lectin that binds to various sugars: galactose > mannose = fucose > N-acetylglucosamine > N-acetylgalactosamine. Acts as a chemoattractant, probably involved in the regulation of cell migration.
Subcellular location. Secreted. Golgi apparatus. Cytoplasm.
Tissue specificity. Highly expressed in liver, placenta and adrenal gland. Moderately expressed in small intestine, lung, stomach and prostate. Weakly expressed in trachea and spleen.
Disease relevance. 3MC syndrome 3 (3MC3) [MIM:248340] A form of 3MC syndrome, an autosomal recessive disorder characterized by facial dysmorphism, craniosynostosis, learning disability, and genital, limb and vesicorenal anomalies. Facial features include hypertelorism, blepharophimosis, blepharoptosis and highly arched eyebrows, cleft lip and/or palate. The term 3MC syndrome includes Carnevale, Mingarelli, Malpuech, and Michels syndromes. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the COLEC10/COLEC11 family.
RefSeq proteins (2): NP_001311024, NP_006429* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001304 | C-type_lectin-like | Domain |
| IPR008160 | Collagen | Repeat |
| IPR016186 | C-type_lectin-like/link_sf | Homologous_superfamily |
| IPR016187 | CTDL_fold | Homologous_superfamily |
| IPR018378 | C-type_lectin_CS | Conserved_site |
| IPR033990 | Collectin_CTLD | Domain |
| IPR051663 | CLec_Tetranectin-domain | Family |
Pfam: PF00059, PF01391
UniProt features (13 total): sequence variant 2, sequence conflict 2, domain 2, disulfide bond 2, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y6Z7-F1 | 81.20 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 176–270, 248–262
Glycosylation sites (1): 258
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-166662 | Lectin pathway of complement activation |
| R-HSA-166663 | Initial triggering of complement |
MSigDB gene sets: 258 (showing top):
BROWNE_HCMV_INFECTION_30MIN_DN, GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS, GOCC_COLLAGEN_TRIMER, REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN, GOCC_CELL_SURFACE, GOBP_VESICLE_MEDIATED_TRANSPORT, FOXO4_01, LHX3_01, AAAYRNCTG_UNKNOWN, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_TAXIS
GO Biological Process (6): complement activation, lectin pathway (GO:0001867), cell surface pattern recognition receptor signaling pathway (GO:0002752), proteolysis (GO:0006508), positive regulation of opsonization (GO:1903028), cranial skeletal system development (GO:1904888), positive chemotaxis (GO:0050918)
GO Molecular Function (4): D-mannose binding (GO:0005537), chemoattractant activity (GO:0042056), protein binding (GO:0005515), carbohydrate binding (GO:0030246)
GO Cellular Component (7): extracellular region (GO:0005576), collagen trimer (GO:0005581), obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), external side of plasma membrane (GO:0009897), serine-type endopeptidase complex (GO:1905370)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Creation of C4 and C2 activators | 1 |
| Complement cascade | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| cellular anatomical structure | 2 |
| complement activation | 1 |
| innate immune response | 1 |
| innate immune response activating cell surface receptor signaling pathway | 1 |
| pattern recognition receptor signaling pathway | 1 |
| protein metabolic process | 1 |
| positive regulation of immune effector process | 1 |
| opsonization | 1 |
| positive regulation of phagocytosis | 1 |
| regulation of opsonization | 1 |
| anatomical structure development | 1 |
| chemotaxis | 1 |
| monosaccharide binding | 1 |
| receptor ligand activity | 1 |
| positive chemotaxis | 1 |
| protein-containing complex | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| plasma membrane | 1 |
| cell surface | 1 |
| side of membrane | 1 |
| serine-type peptidase complex | 1 |
| endopeptidase complex | 1 |
Protein interactions and networks
STRING
790 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COLEC10 | FCN2 | Q15485 | 883 |
| COLEC10 | MASP2 | O00187 | 880 |
| COLEC10 | COLEC11 | Q9BWP8 | 874 |
| COLEC10 | FCN3 | O75636 | 859 |
| COLEC10 | F8W876 | F8W876 | 804 |
| COLEC10 | CD33 | P20138 | 753 |
| COLEC10 | KIR3DL1 | P43629 | 704 |
| COLEC10 | IL3RA | P26951 | 671 |
| COLEC10 | MBL2 | P11226 | 662 |
| COLEC10 | CLEC12A | Q5QGZ9 | 623 |
| COLEC10 | FCN1 | O00602 | 578 |
| COLEC10 | CD38 | P28907 | 571 |
| COLEC10 | CD96 | P40200 | 571 |
| COLEC10 | CCBE1 | Q6UXH8 | 517 |
| COLEC10 | CD47 | Q08722 | 514 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MASP2 | COLEC11 | psi-mi:“MI:0915”(physical association) | 0.520 |
| MASP1 | COLEC11 | psi-mi:“MI:0915”(physical association) | 0.520 |
| COLEC11 | COLEC10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| COLEC10 | COLEC11 | psi-mi:“MI:0915”(physical association) | 0.400 |
| COLEC11 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| COLEC10 | PTX3 | psi-mi:“MI:0914”(association) | 0.350 |
| COLEC10 | PLOD2 | psi-mi:“MI:0914”(association) | 0.350 |
| KRAS | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (39): NUCB2 (Affinity Capture-MS), P3H4 (Affinity Capture-MS), COLGALT2 (Affinity Capture-MS), DNAJB9 (Affinity Capture-MS), CKAP4 (Affinity Capture-MS), MIA3 (Affinity Capture-MS), ARL8A (Affinity Capture-MS), TIMP3 (Affinity Capture-MS), PTX3 (Affinity Capture-MS), STC2 (Affinity Capture-MS), INHBE (Affinity Capture-MS), MCU (Affinity Capture-MS), DCP2 (Affinity Capture-MS), COLEC10 (Co-fractionation), PTX3 (Affinity Capture-MS)
ESM2 similar proteins: B1A4N2, B1A4P2, B1A4P8, B1A4Q3, B1A4Q5, C0STK6, O02659, P06908, P08427, P08661, P11226, P12842, P19999, P23805, P35242, P35247, P35248, P39039, P41317, P42916, P49874, P50403, P50404, Q1PBC5, Q2LK95, Q5M8X6, Q5U9S1, Q66S37, Q66S41, Q66S45, Q66S50, Q66S54, Q66S58, Q66S60, Q66S61, Q66S62, Q66S63, Q66S64, Q66S65, Q6RXL1
Diamond homologs: B1A4M7, B1A4Q6, B1A4Q8, B1A4Q9, B2D1Y0, C0STK6, O02659, P06908, P08427, P08661, P11226, P12842, P19999, P20693, P21755, P23805, P35242, P35246, P35247, P35248, P39039, P42916, P49874, P50403, P50404, P82142, Q1PBC5, Q28062, Q2LK95, Q5M8X6, Q5U9S1, Q61361, Q62028, Q66S60, Q66S61, Q66S62, Q66S63, Q66S64, Q684R7, Q6RXL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 4 |
| Likely pathogenic | 2 |
| Uncertain significance | 44 |
| Likely benign | 8 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (6)
| Variant ID | HGVS | Classification |
|---|---|---|
| 417733 | NM_006438.5(COLEC10):c.25C>T (p.Arg9Ter) | Pathogenic |
| 417734 | NM_006438.5(COLEC10):c.228del (p.Gly77fs) | Pathogenic |
| 417735 | NM_006438.5(COLEC10):c.528C>G (p.Cys176Trp) | Pathogenic |
| 6968 | nsv513786 | Pathogenic |
| 4072585 | NM_006438.5(COLEC10):c.442+1G>A | Likely pathogenic |
| 4081283 | NM_006438.5(COLEC10):c.311G>T (p.Gly104Val) | Likely pathogenic |
SpliceAI
1257 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:119089675:A:AG | acceptor_gain | 1.0000 |
| 8:119089676:A:G | acceptor_gain | 1.0000 |
| 8:119102344:TCAG:T | acceptor_loss | 1.0000 |
| 8:119102345:CAGG:C | acceptor_loss | 1.0000 |
| 8:119102346:A:AG | acceptor_gain | 1.0000 |
| 8:119102347:G:GG | acceptor_gain | 1.0000 |
| 8:119102398:GCAG:G | donor_gain | 1.0000 |
| 8:119102399:CAGGT:C | donor_loss | 1.0000 |
| 8:119102400:AGG:A | donor_loss | 1.0000 |
| 8:119102401:GGT:G | donor_loss | 1.0000 |
| 8:119102402:G:GA | donor_loss | 1.0000 |
| 8:119102654:G:GT | donor_gain | 1.0000 |
| 8:119102692:GCA:G | donor_gain | 1.0000 |
| 8:119102695:G:GG | donor_gain | 1.0000 |
| 8:119103891:GAATG:G | donor_gain | 1.0000 |
| 8:119103896:GTGAG:G | donor_loss | 1.0000 |
| 8:119103897:T:G | donor_loss | 1.0000 |
| 8:119105797:CAGTG:C | acceptor_loss | 1.0000 |
| 8:119105798:A:AG | acceptor_gain | 1.0000 |
| 8:119105798:AGT:A | acceptor_gain | 1.0000 |
| 8:119105799:G:GG | acceptor_gain | 1.0000 |
| 8:119105799:GT:G | acceptor_gain | 1.0000 |
| 8:119105799:GTG:G | acceptor_gain | 1.0000 |
| 8:119105799:GTGA:G | acceptor_gain | 1.0000 |
| 8:119105799:GTGAT:G | acceptor_gain | 1.0000 |
| 8:119089675:AAAAG:A | acceptor_gain | 0.9900 |
| 8:119091219:GG:G | donor_gain | 0.9900 |
| 8:119091220:GG:G | donor_gain | 0.9900 |
| 8:119102333:ATT:A | acceptor_gain | 0.9900 |
| 8:119102335:T:A | acceptor_gain | 0.9900 |
AlphaMissense
1838 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:119106126:T:A | W257R | 0.999 |
| 8:119106126:T:C | W257R | 0.999 |
| 8:119106128:G:C | W257C | 0.999 |
| 8:119106128:G:T | W257C | 0.999 |
| 8:119105883:T:A | C176S | 0.998 |
| 8:119105883:T:C | C176R | 0.998 |
| 8:119105884:G:A | C176Y | 0.998 |
| 8:119105884:G:C | C176S | 0.998 |
| 8:119105885:C:G | C176W | 0.998 |
| 8:119106059:G:C | W234C | 0.998 |
| 8:119106059:G:T | W234C | 0.998 |
| 8:119106165:T:A | C270S | 0.998 |
| 8:119106166:G:C | C270S | 0.998 |
| 8:119106165:T:C | C270R | 0.997 |
| 8:119106166:G:A | C270Y | 0.997 |
| 8:119105914:C:A | P186H | 0.996 |
| 8:119106099:T:A | C248S | 0.996 |
| 8:119106100:G:C | C248S | 0.996 |
| 8:119106166:G:T | C270F | 0.996 |
| 8:119106167:T:G | C270W | 0.996 |
| 8:119105884:G:T | C176F | 0.995 |
| 8:119106099:T:C | C248R | 0.995 |
| 8:119106101:T:G | C248W | 0.995 |
| 8:119106141:T:A | C262S | 0.995 |
| 8:119106142:G:C | C262S | 0.995 |
| 8:119105914:C:G | P186R | 0.994 |
| 8:119106100:G:A | C248Y | 0.994 |
| 8:119106127:G:C | W257S | 0.994 |
| 8:119106141:T:C | C262R | 0.994 |
| 8:119106159:T:C | F268L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000008541 (8:119022198 T>C), RS1000086917 (8:119069194 C>T), RS1000093487 (8:118964532 A>G), RS1000104467 (8:119059713 A>G), RS1000108351 (8:119092395 C>G), RS1000121109 (8:118997667 C>T), RS1000128565 (8:119004367 C>T), RS1000133886 (8:118981826 T>G), RS1000161541 (8:118980280 A>G), RS1000165842 (8:119021567 G>A), RS1000168748 (8:119045914 G>A), RS1000190353 (8:119056013 T>A), RS1000203301 (8:119056332 G>A,C), RS1000214498 (8:119082117 C>T), RS1000237750 (8:119010178 C>T)
Disease associations
OMIM: gene MIM:607620 | disease phenotypes: MIM:248340, MIM:239000
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| 3MC syndrome 3 | Strong | Autosomal recessive |
| 3MC syndrome | Supportive | Autosomal recessive |
Mondo (3): 3MC syndrome 3 (MONDO:0009554), juvenile Paget disease (MONDO:0009394), 3MC syndrome (MONDO:0017398)
Orphanet (3): 3MC syndrome (Orphanet:293843), Juvenile Paget disease (Orphanet:2801), Malpuech syndrome (Orphanet:2453)
HPO phenotypes
48 total (30 of 48 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000028 | Cryptorchidism |
| HP:0000048 | Bifid scrotum |
| HP:0000054 | Micropenis |
| HP:0000085 | Horseshoe kidney |
| HP:0000175 | Cleft palate |
| HP:0000202 | Orofacial cleft |
| HP:0000204 | Cleft upper lip |
| HP:0000316 | Hypertelorism |
| HP:0000365 | Hearing impairment |
| HP:0000369 | Low-set ears |
| HP:0000377 | Abnormal pinna morphology |
| HP:0000494 | Downslanted palpebral fissures |
| HP:0000506 | Telecanthus |
| HP:0000508 | Ptosis |
| HP:0000537 | Epicanthus inversus |
| HP:0000581 | Blepharophimosis |
| HP:0000593 | Abnormal anterior chamber morphology |
| HP:0000808 | Penoscrotal hypospadias |
| HP:0000960 | Sacral dimple |
| HP:0001249 | Intellectual disability |
| HP:0001263 | Global developmental delay |
| HP:0001363 | Craniosynostosis |
| HP:0001510 | Growth delay |
| HP:0001537 | Umbilical hernia |
| HP:0001540 | Diastasis recti |
| HP:0002006 | Tessier cleft |
| HP:0002265 | Large fleshy ears |
| HP:0002553 | Highly arched eyebrow |
| HP:0002558 | Supernumerary nipple |
GWAS associations
17 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002493_13 | Bone mineral density (paediatric, skull) | 2.000000e-11 |
| GCST002493_14 | Bone mineral density (paediatric, skull) | 3.000000e-08 |
| GCST002546_1 | Osteoprotegerin levels | 8.000000e-15 |
| GCST002546_4 | Osteoprotegerin levels | 8.000000e-09 |
| GCST002587_13 | Blood pressure (smoking interaction) | 2.000000e-07 |
| GCST002587_14 | Blood pressure (smoking interaction) | 4.000000e-06 |
| GCST005212_12 | Asthma | 5.000000e-06 |
| GCST006979_366 | Heel bone mineral density | 4.000000e-12 |
| GCST007800_93 | Asthma (childhood onset) | 8.000000e-11 |
| GCST010059_10 | Physiological traits | 5.000000e-06 |
| GCST010653_16 | Thyroid stimulating hormone levels | 4.000000e-08 |
| GCST011353_50 | Serum alkaline phosphatase levels | 1.000000e-27 |
| GCST90002382_251 | Eosinophil percentage of white cells | 1.000000e-09 |
| GCST90002388_259 | Lymphocyte count | 3.000000e-10 |
| GCST90011899_152 | Aspartate aminotransferase levels | 6.000000e-09 |
| GCST90013407_199 | Liver enzyme levels (gamma-glutamyl transferase) | 1.000000e-19 |
| GCST90014023_26 | Type 1 diabetes | 3.000000e-10 |
EFO canonical traits (10, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0006526 | pack-years measurement |
| EFO:0006525 | cigarettes per day measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0005937 | longitudinal BMI measurement |
| EFO:0004533 | alkaline phosphatase measurement |
| EFO:0007991 | eosinophil percentage of leukocytes |
| EFO:0004587 | lymphocyte count |
| EFO:0004736 | aspartate aminotransferase measurement |
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
MeSH disease descriptors (2)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C537701 | Hyperostosis corticalis deformans juvenilis (supp.) | |
| C535704 | Malpuech facial clefting syndrome (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
3 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs2073618 | COLEC10, TNFRSF11B | 3 | 6.25 | 1 | anastrozole;letrozole |
| rs2465403 | COLEC10 | 0.00 | 0 | ||
| rs3134068 | COLEC10, TNFRSF11B | 0.00 | 0 |
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Fluorocarbons | affects cotreatment, increases expression | 1 |
| Hydrocarbons, Chlorinated | affects cotreatment, increases expression | 1 |
| Metals | affects cotreatment, increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Pentachlorophenol | affects cotreatment, increases expression | 1 |
| Polychlorinated Biphenyls | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: 3MC syndrome, 3MC syndrome 3
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): 3MC syndrome, 3MC syndrome 3, juvenile Paget disease